SLAM
BSX icon

Swiss Life Asset Management’s Boston Scientific BSX Stock Holding History

Swiss Life Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.1M Buy
213,308
+25,572
+14% +$1.39M 0.04% 338
2026
Q1 		$11.8M Buy
187,736
+20,433
+12% +$1.63M 0.06% 244
2025
Q4 		$16M Buy
167,303
+7,631
+5% +$748K 0.08% 187
2025
Q3 		$15.6M Sell
159,672
-11,567
-7% -$1.2M 0.08% 187
2025
Q2 		$18.4M Buy
171,239
+34,964
+26% +$3.54M 0.11% 149
2025
Q1 		$13.7M Buy
136,275
+27,043
+25% +$2.72M 0.1% 161
2024
Q4 		$9.74M Buy
109,232
+60,846
+126% +$5.36M 0.07% 200
2024
Q3 		$4.05M Sell
48,386
-9,159
-16% -$722K 0.05% 283
2024
Q2 		$4.43M Buy
57,545
+9,583
+20% +$701K 0.05% 268
2024
Q1 		$3.28M Sell
47,962
-103,138
-68% -$6.63M 0.05% 278
2023
Q4 		$8.75M Buy
151,100
+77,799
+106% +$4.15M 0.11% 220
2023
Q3 		$3.87M Sell
73,301
-51,332
-41% -$2.69M 0.06% 338
2023
Q2 		$6.74M Sell
124,633
-731
-0.6% -$38.2K 0.1% 248
2023
Q1 		$6.27M Buy
125,364
+59,748
+91% +$2.82M 0.09% 269
2022
Q4 		$3.04M Buy
65,616
+4,465
+7% +$193K 0.05% 371
2022
Q3 		$2.37M Sell
61,151
-215
-0.4% -$8.63K 0.04% 413
2022
Q2 		$2.29M Sell
61,366
-40,292
-40% -$1.64M 0.04% 419
2022
Q1 		$4.5M Buy
101,658
+23
+0% +$997 0.06% 313
2021
Q4 		$4.32M Sell
101,635
-2,735
-3% -$115K 0.06% 335
2021
Q3 		$4.53M Sell
104,370
-28,736
-22% -$1.27M 0.06% 304
2021
Q2 		$6.45M Buy
133,106
+8,856
+7% +$373K 0.07% 278
2021
Q1 		$4.8M Buy
124,250
+1,421
+1% +$53.8K 0.07% 312
2020
Q4 		$4.42M Buy
122,829
+111,900
+1,024% +$4.03M 0.06% 310
2020
Q3 		$417K Hold
10,929
– – 0.01% 427
2020
Q2 		$384K Sell
10,929
-20,639
-65% -$743K 0.01% 457
2020
Q1 		$1.03M Sell
31,568
-2,286
-7% -$89.3K 0.02% 371
2019
Q4 		$1.53M Sell
33,854
-3,977
-11% -$166K 0.03% 373
2019
Q3 		$1.54M Buy
37,831
+25,838
+215% +$1.09M 0.02% 374
2019
Q2 		$514K Hold
11,993
– – 0.01% 457
2019
Q1 		$460K Sell
11,993
-3,047
-20% -$116K 0.01% 426
2018
Q4 		$532K Sell
15,040
-19,967
-57% -$724K 0.01% 170
2018
Q3 		$1.35M Sell
35,007
-29,297
-46% -$1.02M 0.02% 366
2018
Q2 		$2.1M Buy
64,304
+50,028
+350% +$1.51M 0.03% 287
2018
Q1 		$390K Sell
14,276
-73,840
-84% -$2.01M 0.01% 432
2017
Q4 		$2.19M Buy
88,116
+6,058
+7% +$167K 0.05% 202
2017
Q3 		$2.39M Buy
82,058
+51,437
+168% +$1.42M 0.06% 183
2017
Q2 		$848K Buy
30,621
+2,769
+10% +$73.5K 0.02% 360
2017
Q1 		$693K Buy
+27,852
New +$677K 0.02% 352
2016
Q4 		– Sell
-8,705
Closed -$207K – 434
2016
Q3 		$207K Sell
8,705
-29,395
-77% -$701K 0.01% 407
2016
Q2 		$890K Buy
+38,100
New +$824K 0.04% 181
2016
Q1 		– Sell
-40,907
Closed -$754K – 357
2015
Q4 		$754K Buy
40,907
+4,146
+11% +$74.3K 0.03% 187
2015
Q3 		$603K Buy
36,761
+14,379
+64% +$246K 0.03% 188
2015
Q2 		$396K Buy
+22,382
New +$400K 0.01% 214

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Swiss Life Asset Management's BSX Position: Q2 2026 in Review

Swiss Life Asset Management increased its Boston Scientific (BSX) stake by 14% in Q2 2026, buying an estimated $1.39M and bringing the position to 213,308 shares worth $9.1M. The position accounts for 0.04% of the portfolio, ranked #338.

Swiss Life Asset Management first reported a position in BSX in Q2 2015 and has held it in 43 quarters since. The position peaked at $18.4M in Q2 2025. 1,039 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Swiss Life Asset Management held 213,308 shares of Boston Scientific worth $9.1M as of Q2 2026.
  • Swiss Life Asset Management bought 25,572 Boston Scientific shares in Q2 2026, an estimated $1.39M.
  • Boston Scientific made up 0.04% of Swiss Life Asset Management's portfolio in Q2 2026, its #338 holding.
  • Swiss Life Asset Management first reported a position in Boston Scientific in Q2 2015 and has held it in 43 quarters since.
  • Swiss Life Asset Management's Boston Scientific position peaked at $18.4M in Q2 2025.
  • 1,039 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.